Researchers have completed the first gene therapy procedure aimed at stoping age-related macular degeneration. Dr. Allen Ho commented, “What’s unique about this particular clinical trial is that they are trying gene therapy surgically delivered to the sub retinal space to try to modify the disease process of dry macular degeneration." Read the full article from... read more
Diabetic retinopathy is the most common cause of vision loss among people with diabetes and is the most frequent cause of new cases of blindness among adults ages 20 to 74. Dr. Omesh Gupta discusses how treatments have radically improved in the recent years. Read the full article here from AARP.
"Dr. Regillo cared for my dad at Mid Atlantic Retina’s Newtown Square office, and we very much appreciate his attention to my dad's well being - no one looks forward to a “shot in the eye ball”, but his administering of Dad’s care was superb. Upon seeing the article from The Inquirer, I reminded my... read more
Association of Intravitreal Anti–Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration
A study recently done out of the Mayo Clinic, looked into the risk of strokes due to anti-VEGF therapy for AMD. The study has found that there is no association between the two, and the use of anti-VEGF therapy is still the best option for patients with AMD. Dr. Carl Regillo added his own comment... read more
Dr. Allen Ho and Dr. Carl Regillo attended the annual Hawaiian Eye & Retina Meeting from January 20-25 and presented on a number of topics. Dr. Ho spoke about “New RPE cell-based treatments in development for dry AMD”, and you can watch the video here from Healio. Dr. Regillo presented on... read more
Dr. Sunir Garg, co-author of a study looking into how statins can help prevent diabetic retinopathy, says, “Statins may actually help patients’ eyeballs as well, not just their hearts.” Read more on this study about how people with diabetes could benefit from using statins to delay the risk of diabetic retinopathy.
Dr. Jason Hsu leads a study that looks into the loss of follow-up visits with patients suffering from non-proliferative diabetic retinopathy. The study has found that a quarter of patients do not return within a year of receiving an anti-VEGF injection. Read more about the study from Healio.
Dr. Carl Regillo, Chief of Wills Eye Retina Service, explains the risk diabetes imposes on your vision if not treated or detected early. Watch the full clip here to learn more.
"I am so grateful for the staff at the Lansdale office. Eye injections are not the highlight of anyone's day. But - thanks to this group it makes it tolerable (not pleasant but not the worst thing). They are welcoming (even with the number of patients waiting in the wings), have a great sense of... read more
Melinda Roth feels fortunate. The vision in her left eye went from “a big black blotchy circle” to nearly normal thanks to a drug that stopped the growth of abnormal blood vessels. This is a new treatment for macular degeneration being studied by doctors at Wills Eye and Mid Atlantic Retina with Dr. Carl Regillo as... read more